Skip to content

Clinical trials

Phase 1 Peripheral Vascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Vascular Diseases Phase: Phase 1 Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20043
20051
20062
20074
20081
20093
20111
20141
20153
20163
20172
20181
20202
20211
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status10
Active, not recruiting1
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jie Shen3
Alucent Biomedical2
National Heart, Lung, and Blood Institute (NHLBI)2
Pluristem Ltd.2
Ageless Regenerative Institute1
Allife Medical Science and Technology Co., Ltd.1
Arteriocyte, Inc.1
Grifols Therapeutics LLC1
Indiana University1
Louis Messina1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Vascular Diseases31
Peripheral Arterial Disease11
Chronic Limb-Threatening Ischemia7
Ischemia5
Diabetic Foot4
Intermittent Claudication4
Arterial Occlusive Diseases2
Arteriosclerosis2
Atherosclerosis2
Gangrene2

Trials

Showing 51 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.